Disease: Neurofibromatosis type 3
- <em>Drosophila</em> Contributions towards Understanding Neurofibromatosis 1
- <em>NF1</em>-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of <em>NF1</em>-Mutant Rhabdomyosarcoma and <em>NF1</em>-Associated Malignant Triton Tumor
- A 23-year-female with plexiform neurofibroma type 1: a rare clinical image
- A Case of Small Intestinal GIST Associated with Neurofibromatosis Type 1
- A case report of giant malignant schwannoma of the sciatic nerve associated with neurofibromatosis-1: A CARE-compliant article
- A genetic study to understand more about the variability in appearance, number and growth of neurofibromas in people with neurofibromatosis type 1
- A Giant Scrotal Neurofibroma in a Child Masquerading as Filariasis: Uncommon Presentation of a Common Disease
- A neurofibromatosis patient with a large appendix and multiple small intestine masses
- A new frameshift mutation in a patient with neurofibromatosis type I
- A Systematic Review on Visual-Processing Deficits in Neurofibromatosis Type 1: What Possible Impact on Learning to Read?
- Acquired myelinated retinal nerve fiber layer in a child with neurofibromatosis 1-related optic pathway glioma
- An Uncommon Coexistence of Dural and Intraventricular Meningiomas
- Analysis of clinical features and variants of NF1 gene in 12 patients with Neurofibromatosis type 1
- Analysis of NF1 gene variants in a Chinese pedigree and a sporadic patient with Neurofibromatosis type 1
- Auditory brainstem implant: current states and future prospects
- Auditory brainstem implants for hearing rehabilitation in NF2-schwannomatosis: A systematic review and single-arm meta-analysis
- Autism spectrum disorder profiles in RASopathies: A systematic review
- Automatic Visual Acuity Loss Prediction in Children with Optic Pathway Gliomas using Magnetic Resonance Imaging
- Bone mineral density, vitamin D and osseous metabolism indices in neurofibromatosis type 1: A systematic review and meta-analysis
- Brain injury drives optic glioma formation through neuron-glia signaling
- Breast density in NF1 women: a retrospective study
- Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis
- Clinical characteristics of epileptic seizure in neurofibromatosis type 1 in 15 cases
- Concurrent spinal meningioma and giant invasive schwannoma without neurofibromatosis in children: A case report and literature review
- Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1
- Diverse learners: learning disabilities and quality of life following mind-body and health education interventions for adults with neurofibromatosis
- Droplet Digital PCR for Fast and Accurate Characterization of NF1 Locus Deletions: Confirmation of the Predominant Maternal Origin of Type-1 Deletions
- Econazole selectively induces cell death in NF1-homozygous mutant tumor cells
- Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1
- Efficacy and safety of selumetinib in patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: a systematic review and meta-analysis
- Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1
- Epilepsy in Legius syndrome: Coincidence or causation?
- Epilepsy in neurofibromatosis type 1: Prevalence, phenotype, and genotype in adults
- Estrogen-induced glial IL-1β mediates extrinsic retinal ganglion cell vulnerability in murine Nf1 optic glioma
- Expression analysis of NF1-mutated alleles in a rare compound heterozygous spinal NF1 patient by digital PCR
- Frequency of Acne and Acne Scars in Patients with Neurofibromatosis 1
- FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells
- Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance
- Gene therapy strategies and prospects for neurofibromatosis type 1
- Genetically confirmed coexistence of neurofibromatosis type 1 and Cherubism in a pediatric patient
- Genotype-phenotype correlations of neurofibromatosis type 1: a cross-sectional study from a large Chinese cohort
- Giant gluteal and vesical plexiform neurofibromas in a patient with neurofibromatosis type 1: a case report
- Gonadal and gonadosomatic mosaicism in NF1: report of two families
- Gonadales und gonadosomatisches Neurofibromatose-Typ-1-Mosaik: ein Bericht über zwei Familien: Gonadal and gonadosomatic mosaicism in NF1: report of two families
- High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity
- Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1)
- How to score the impact of treatment on cutaneous neurofibromas in clinical trials
- HSR24-150: Real-World Treatment Patterns of Selumetinib Among Patients With Neurofibromatosis Type I and Plexiform Neurofibroma in the United States
- Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes
- Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools
- Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma
- Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1
- Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey
- Improved sensitivity for detection of pathogenic variants in familial <em>NF2</em>-related schwannomatosis
- Living with… neurofibromatosis type 1
- Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective
- Mindfulness, coping, and optimism as mechanisms of change in the 3RP-NF intervention
- Minimal clinically important difference in the World Health Organization Quality of Life Brief (WHOQOL-BREF) for adults with neurofibromatosis
- Multidisciplinary team for patients with neurocutaneous syndromes: The little discussed importance of dentistry
- Multimodal Imaging of Choroidal Nodules in Neurofibromatosis Type I
- Neurofibromatosis Type 1 Vasculopathy Presenting as Branch Retinal Vein Occlusion: Case Report and Review of the Literature
- Neurofibromatosis type 2 in the otorhinolaryngological practice
- Neurofibromin 1 controls metabolic balance and Notch-dependent quiescence of murine juvenile myogenic progenitors
- Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia
- NF1 deficiency drives metabolic reprogramming in ER+ breast cancer
- Noninvasive treatment of cutaneous neurofibromas (cNFs): Results of a randomized prospective, direct comparison of four methods
- Outcomes that need to be assessed in clinical trials for cutaneous neurofibromas in people with neurofibromatosis type 1
- Patient characteristics, treatment patterns, healthcare resource utilization, and costs among patients diagnosed with neurofibromatosis type 1 with and without plexiform neurofibromas in Japan
- Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials
- Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1
- Plexiform neurofibroma masquerading as a giant congenital melanocytic nevus
- Quality of life in patients with neurofibromatosis type 1: a nationwide database study in Japan from 2015 to 2019
- Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma
- Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials
- Recurrent spontaneous pneumothorax in an NF1 patient with a novel causative variant: broadening genotype-phenotype correlations
- Resiliency outcomes after participation in an asynchronous web-based platform for adults with neurofibromatosis: The NF-Web study
- Robotic resection for splenic artery aneurysm associated with neurofibromatosis type 1: a case report
- Safety, pharmacokinetics and efficacy of selumetinib in Chinese adult and paediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: The primary analysis of a phase 1 open-label study
- Schwann cells modulate nociception in neurofibromatosis 1
- Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas: A plain language summary of SPRINT
- Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis
- Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression
- Spontaneous radiological regression of optic nerve glioma in a child: A dilemma
- Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis
- Symptomatic tumors in neurofibromatosis type 1: a diagnostic challenge
- The impact of a virtual mind-body program on symptoms of depression and anxiety among international English-speaking adults with neurofibromatosis
- The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis
- The management of neurofibromatosis type 1 (NF1) in children and adolescents
- The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands
- The Relationship Between Choroidal Abnormalities and Visual Outcomes in Pediatric Patients With NF1-Associated Optic Pathway Gliomas
- The role of scoliosis on the comorbidity and demographics of neurofibromatosis type 1 patients: A retrospective analysis of the National Inpatient Sample database
- Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1
- Transmaxillary approach for resection of maxillary division trigeminal schwannoma at foramen rotundum
- Treatment evaluation by volumetric segmentation in pediatric optic pathway glioma: evaluation of the effect of bevacizumab on intra-tumor components
- Treatment With Selumetinib for Café-au-Lait Macules and Plexiform Neurofibroma in Pediatric Patients With Neurofibromatosis Type 1
- Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas
- Understanding chronic pain in Neurofibromatosis Type 1 using the Neurofibromatosis Pain Module (NFPM)
- Whole-body <sup>18</sup>F-FDG-PET/MRI as a screening tool for the detection of malignant transformation in individuals with Neurofibromatosis type 1
- Whole-Body Positron Emission Tomography with <sup>18</sup>F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1
- Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy